We have added some new platforms in #3281 and we should confirm that processing samples from these platforms do not error out at an exceeding rate. I do not expect this to be the case but I am making this ticket just to make sure we do check.
Problem or idea
After merging in #3281 we should wait some time to collect a history of processing success / failure. Then we should confirm that these platforms have a success rate similar to existing supported RNA-seq platforms.
Solution or next step
I will set a reminder for a few weeks after this is merged into production to pick up this ticket. I expect the easiest way to approach this problem will be to use the API or to create a management command that allows us to quickly get success rate for a specific platform.
Context
We have added some new platforms in #3281 and we should confirm that processing samples from these platforms do not error out at an exceeding rate. I do not expect this to be the case but I am making this ticket just to make sure we do check.
Problem or idea
After merging in #3281 we should wait some time to collect a history of processing success / failure. Then we should confirm that these platforms have a success rate similar to existing supported RNA-seq platforms.
Solution or next step
I will set a reminder for a few weeks after this is merged into production to pick up this ticket. I expect the easiest way to approach this problem will be to use the API or to create a management command that allows us to quickly get success rate for a specific platform.